Arkema selects Singapore for the production of its Rilsan® high-performance bio-sourced polyamides

- Press release
Corporate - Finance - Products
Arkema has chosen the location of Jurong Island in Singapore to build its new world-scale plant dedicated to the manufacture of the amino 11 monomer and its flagship Rilsan® polyamide 11 resins. With this 50% increase in its global capacities announced in July 2017, the Group supports strong demand from its customers in Asia for high-performance bio-sourced solutions addressing the major opportunity of material lightweighting in particular.

Arkema has chosen the Jurong Island site in Singapore to set up its new bio-sourced polyamide production site. This location offers many advantages in terms of infrastructure, logistics, industrial integration and operational excellence, as well as optimization of the activity’s carbon footprint.

Use of 2-Octanol to make acrylates, maleates (green polymerization) and phtalates (plastic).

 

 

 

Rilsan® polyamide 11 is derived from castor oil and so is the only 100% bio-sourced polyamide approved for many of the most demanding applications, in particular in the electronics, 3D printing, oil and gas extraction, and automotive markets, as a substitute to metal.

This project is part of the Group’s exceptional investments totaling some 500 million euros earmarked for the 2018-2021 period essentially. Construction is scheduled to be completed by late 2021.

Contacts

Béatrice ZILM
Investor relations
Tel: +33 (0)1 49 00 86 37
Send an email
Mathieu BRIATTA
Investor relations
Tel: +33 (0)1 49 00 72 07
Send an email
Gilles GALINIER
VP Communication
Tel: +33 (0)1 49 00 70 07
Arkema
Send an email
Véronique OBRECHT
Corporate Press relations
Tel: +33 (0)1 49 00 88 41
Arkema
Send an email
Search engine
Europe
Asia
Americas
Group website
Main brands
Discover our main brands website
Contact
Contact